Form 4: GE HealthCare Technologies Inc. Executive Taha Kass-Hout Reports Stock and Option Awards
SEC Form 4 Filing
Chief Technology Officer Taha Kass-Hout reports the acquisition of restricted stock units and stock options in GE HealthCare Technologies Inc.
Summary
- Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., filed a Form 4 with the SEC.
- The report details the acquisition of 9,976 restricted stock units and 28,374 employee stock options on March 1, 2024.
- The restricted stock units will vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
- Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
- The employee stock options, with an exercise price of $92.72, also vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
- Following these transactions, Kass-Hout directly owns 70,600 shares of GE HealthCare common stock and 28,374 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options and restricted stock units is a standard practice and aligns executive interests with shareholders. The vesting schedule promotes long-term commitment.
Positives
- The granting of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The vesting schedule of the restricted stock units and stock options extends to September 1, 2027, indicating a long-term incentive structure.
Industry Context
Stock option and restricted stock unit grants are a common practice in the healthcare technology industry to attract and retain top talent and align their interests with company performance.
Comparison to Industry Standards
- Companies like Siemens Healthineers and Philips also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedules and grant sizes are generally comparable to industry standards for similar executive roles.
Stakeholder Impact
- The granting of stock options and restricted stock units can positively impact shareholders by aligning executive interests with company performance.
- Employees may be motivated by the potential for future stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: Award of restricted stock units and employee stock options. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
| 09/01/2025 | First vesting date for 33% of the restricted stock units and stock options. |
| 09/01/2026 | Second vesting date for 33% of the restricted stock units and stock options. |
| 09/01/2027 | Final vesting date for 34% of the restricted stock units and stock options. |
| 03/01/2034 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.